Atai Life Sciences Total Liabilities and Share Holders Equity 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Atai Life Sciences total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

Atai Life Sciences Total Liabilities and Share Holders Equity 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Atai Life Sciences total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$21.4B
Quest Diagnostics (DGX)	$17.3B
DaVita (DVA)	$13.7B
Encompass Health (EHC)	$9.3B
Chemed (CHE)	$8.7B
Elanco Animal Health (ELAN)	$7.2B
Option Care Health (OPCH)	$5.3B
RadNet (RDNT)	$5B
Amedisys (AMED)	$3.2B
Astrana Health (ASTH)	$2.8B
LifeStance Health (LFST)	$2.6B
Addus HomeCare (ADUS)	$2.4B
U.S Physical Therapy (USPH)	$1.3B
Pennant (PNTG)	$1.1B
Aveanna Healthcare Holdings (AVAH)	$1B
Daxor (DXR)	$45M
ATI Physical Therapy (ATIP)	$25M
MEDIROM Healthcare Technologies (MRM)	$19M
Psychemedics (PMD)	$14M
Ontrak (OTRK)	$10M
Novo Integrated Sciences (NVOS)	$6M
IMAC Holdings (BACK)	$2M